AP2014007399A0 - Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament - Google Patents

Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament

Info

Publication number
AP2014007399A0
AP2014007399A0 AP2014007399A AP2014007399A AP2014007399A0 AP 2014007399 A0 AP2014007399 A0 AP 2014007399A0 AP 2014007399 A AP2014007399 A AP 2014007399A AP 2014007399 A AP2014007399 A AP 2014007399A AP 2014007399 A0 AP2014007399 A0 AP 2014007399A0
Authority
AP
ARIPO
Prior art keywords
methanones
aza
medicament
phenyl
andthe use
Prior art date
Application number
AP2014007399A
Other languages
English (en)
Inventor
Barbara Bertani
Marco Ferrara
Riccardo Giovannini
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AP2014007399A0 publication Critical patent/AP2014007399A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2014007399A 2011-08-03 2012-08-02 Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament AP2014007399A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11176468 2011-08-03
PCT/EP2012/065140 WO2013017657A1 (en) 2011-08-03 2012-08-02 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament

Publications (1)

Publication Number Publication Date
AP2014007399A0 true AP2014007399A0 (en) 2014-01-31

Family

ID=46598566

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2014007399A AP2014007399A0 (en) 2011-08-03 2012-08-02 Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament

Country Status (37)

Country Link
US (1) US9012489B2 (lt)
EP (1) EP2739615B1 (lt)
JP (1) JP5850589B2 (lt)
KR (1) KR101944686B1 (lt)
CN (2) CN103797005B (lt)
AP (1) AP2014007399A0 (lt)
AR (1) AR087436A1 (lt)
AU (1) AU2012292036C1 (lt)
BR (1) BR112014001642B1 (lt)
CA (1) CA2843805C (lt)
CL (1) CL2014000246A1 (lt)
CO (1) CO6870037A2 (lt)
CY (1) CY1119326T1 (lt)
DK (1) DK2739615T3 (lt)
EA (1) EA024933B1 (lt)
EC (1) ECSP14013221A (lt)
ES (1) ES2623006T3 (lt)
GE (1) GEP20166483B (lt)
HK (1) HK1193100A1 (lt)
HR (1) HRP20170695T1 (lt)
HU (1) HUE033134T2 (lt)
IL (1) IL229962A (lt)
LT (1) LT2739615T (lt)
MA (1) MA35286B1 (lt)
ME (1) ME02672B (lt)
MX (1) MX347828B (lt)
MY (1) MY167396A (lt)
PE (1) PE20141352A1 (lt)
PL (1) PL2739615T3 (lt)
PT (1) PT2739615T (lt)
RS (1) RS55927B1 (lt)
SI (1) SI2739615T1 (lt)
TN (1) TN2014000044A1 (lt)
TW (1) TWI543974B (lt)
UA (1) UA114405C2 (lt)
UY (1) UY34239A (lt)
WO (1) WO2013017657A1 (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122021017872B1 (pt) 2014-06-06 2021-11-23 Basf Se Uso dos compostos, composição agroquímica e método para o combate dos fungos fitopatogênicos
AR106679A1 (es) 2015-11-13 2018-02-07 Basf Se Oxadiazoles sustituidos para combatir hongos fitopatógenos
US10492494B2 (en) 2015-11-13 2019-12-03 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
JP2018537457A (ja) 2015-11-19 2018-12-20 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se 植物病原菌を駆除するための置換オキサジアゾール
US10986839B2 (en) 2016-04-11 2021-04-27 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2018224455A1 (en) 2017-06-07 2018-12-13 Basf Se Substituted cyclopropyl derivatives
CN113784966B (zh) 2019-05-01 2024-07-19 勃林格殷格翰国际有限公司 Glyt1抑制剂的固体形式
CN115279372A (zh) 2020-01-09 2022-11-01 迪斯克医药公司 用甘氨酸转运蛋白抑制剂治疗红细胞生成性原卟啉病、x连锁原卟啉病或先天性红细胞生成性卟啉病的方法
JP2023537963A (ja) 2020-08-13 2023-09-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 統合失調症に伴う認知機能障害に対する処置法
MX2023004293A (es) 2020-10-13 2023-05-03 Boehringer Ingelheim Int Proceso de reelaboracion.
IL313067A (en) * 2021-11-24 2024-07-01 Maplight Therapeutics Inc Methods for treating neurological disorders
CN114957087A (zh) * 2022-04-13 2022-08-30 湖南复瑞生物医药技术有限责任公司 一种帕罗韦德中间体制备方法
WO2023237103A1 (zh) * 2022-06-10 2023-12-14 成都百裕制药股份有限公司 吡咯烷衍生物、药物组合物及其在医药上的应用
WO2024042043A1 (en) 2022-08-24 2024-02-29 Boehringer Ingelheim International Gmbh A scalable process for the preparation of a glyt-1 inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003214535B2 (en) * 2003-04-10 2009-09-03 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
DK1680124T3 (en) 2003-10-14 2017-08-21 Pfizer Prod Inc Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
DE102004035280A1 (de) 2004-07-21 2006-03-16 Robert Bosch Gmbh Kraftstoffinjektor mit direkter mehrstufiger Einspritzventilgliedansteuerung
BRPI0519744A2 (pt) * 2005-01-06 2009-03-10 Hoffmann La Roche metanonas de fenila substituÍda por sulfanila como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distérbios neurolàgicos e neuropsiquiÁtricos
BRPI0519794A2 (pt) * 2005-01-07 2009-03-17 Hoffmann La Roche derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
RS51204B (sr) * 2005-02-07 2010-12-31 F. Hoffmann-La Roche Ag. Heterociklični supstituisani fenil metanoni kao inhibitori glicin transportera 1
CA2653355C (en) * 2006-06-22 2014-04-15 F. Hoffmann-La Roche Ag Substituted phenyl methanone derivatives
DK2041088T3 (da) 2006-06-28 2014-04-07 Amgen Inc Glycintransporter-1 inhibitorer
AR064561A1 (es) * 2006-12-28 2009-04-08 Actelion Pharmaceuticals Ltd Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
JP2012514006A (ja) * 2008-12-29 2012-06-21 バンダービルト ユニバーシティ 3.1.0二環式GlyT1阻害剤ならびにその作製および使用の方法
AU2010209816A1 (en) 2009-01-27 2011-08-11 F. Hoffmann-La Roche Ag Aroylamino - and heteroaroylamino-substituted piperidines as GlyT-1 inhibitors

Also Published As

Publication number Publication date
SI2739615T1 (sl) 2017-07-31
PE20141352A1 (es) 2014-10-12
CO6870037A2 (es) 2014-02-20
AU2012292036C1 (en) 2017-03-23
ME02672B (me) 2017-06-20
HK1193100A1 (zh) 2014-09-12
TW201321364A (zh) 2013-06-01
BR112014001642B1 (pt) 2022-03-22
AU2012292036A1 (en) 2014-01-16
WO2013017657A1 (en) 2013-02-07
ES2623006T3 (es) 2017-07-10
JP2014524414A (ja) 2014-09-22
EP2739615A1 (en) 2014-06-11
MX2014001252A (es) 2014-05-13
GEP20166483B (en) 2016-05-25
ECSP14013221A (es) 2014-03-31
US9012489B2 (en) 2015-04-21
MX347828B (es) 2017-05-15
HRP20170695T1 (hr) 2017-07-28
JP5850589B2 (ja) 2016-02-03
UA114405C2 (uk) 2017-06-12
BR112014001642A2 (pt) 2017-02-14
EP2739615B1 (en) 2017-03-15
CA2843805A1 (en) 2013-02-07
EA201400183A1 (ru) 2014-06-30
CA2843805C (en) 2021-03-23
TWI543974B (zh) 2016-08-01
EA024933B1 (ru) 2016-11-30
KR20140051922A (ko) 2014-05-02
CY1119326T1 (el) 2018-02-14
CN105837562A (zh) 2016-08-10
LT2739615T (lt) 2017-04-10
MY167396A (en) 2018-08-16
AR087436A1 (es) 2014-03-26
TN2014000044A1 (en) 2015-07-01
PT2739615T (pt) 2017-06-09
IL229962A (en) 2016-09-29
NZ619258A (en) 2015-12-24
US20130197011A1 (en) 2013-08-01
CL2014000246A1 (es) 2014-08-08
UY34239A (es) 2013-02-28
PL2739615T3 (pl) 2017-08-31
CN103797005A (zh) 2014-05-14
MA35286B1 (fr) 2014-07-03
HUE033134T2 (en) 2017-11-28
KR101944686B1 (ko) 2019-02-01
CN103797005B (zh) 2016-05-11
CN105837562B (zh) 2020-01-17
DK2739615T3 (en) 2017-05-08
AU2012292036B2 (en) 2016-10-06
RS55927B1 (sr) 2017-09-29

Similar Documents

Publication Publication Date Title
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
HK1197242A1 (en) Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines -56--4h-[13]
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
ZA201503682B (en) 3,3'-dinitro-5,5'-bistriazole-1,1'-diol
HUE041320T2 (hu) 1,3-Specifikus intraészterezés
Wasti Sagarmatha
Millares Ecocalypso
Milićević Marsov krater Milanković
AU2012903933A0 (en) Chaz's Knotchamacallit
AU336245S (en) 'Friendly' tunic
GB201113678D0 (en) "Data-Tank"
EP2627655A4 (en) THERAPEUTIC 5,6,5-TRICYCLIC ANALOGUES
GB201114480D0 (en) Concept 9
GB201114478D0 (en) Concept 11
GB201114535D0 (en) Concept 38
GB201114532D0 (en) Concept 36
GB201114522D0 (en) Concept 32
GB201114530D0 (en) Concept 35
GB201114529D0 (en) Concept 34
GB201114489D0 (en) Concept 12 12
GB201114472D0 (en) Concept 14
GB201114517D0 (en) Concept 15
GB201114534D0 (en) Concept 37